Partner Content: Highlights
Top videos
Events & Jobs
Upcoming events
Current jobs
Current CME continuing education
View Post

Pathomechanisms, secondary prevention and treatment options

Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right and therefore also a comorbidity. Globally, there has been a rapid increase in prevalence over the last few decades, with more than one billion people affected by 2024. The obesity epidemic is a phenomenon that is being addressed by national and international cardiology societies in particular and discussed in corresponding consensus statements and guidelines…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post

Communication as the key to therapy adherence

Patient satisfaction and adherence depend crucially on the doctor-patient discussion. Communication skills are usually the key to success here. Good interview conditions, sufficient time and an empathetic approach to the diagnosis…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post

Pathomechanisms, secondary prevention and treatment options

Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right and therefore also a comorbidity. Globally, there has been a rapid increase in prevalence over the last few decades, with more than one billion people affected by 2024. The obesity epidemic is a phenomenon that is being addressed by national and international cardiology societies in particular and discussed in corresponding consensus statements and guidelines…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post

Dr. ChatGPT: Large language models in everyday clinical practice

With the public availability of ChatGPT 3.5 in fall 2022 at the latest, artificial intelligence in the sense of large language models (L LMs) is on everyone’s lips. However, it is often forgotten that this is only the provisional end point of decades of development of artificial intelligence, which, despite its great potential, still has many limitations. The question for practising doctors is how this technology can be used sensibly in everyday clinical practice – and how it should not be used…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here